T1	Participants 84 119	early stage cancer of the esophagus
T2	Participants 192 232	early stage cancer of the upper GI tract
T3	Participants 487 533	72 patients with early stage esophageal cancer
T4	Participants 1468 1512	patients who had prior endoscopic treatment.
